Synchrony Financial’s stock narrative has shifted slightly following recent analyst updates, with the fair value estimate ticking up from $82.57 to $82.74 and the discount rate nudging lower from 9.12% to 9.05%. These modest adjustments stem from resilience in revenue growth and credit performance. However, they also reflect ongoing market caution given macroeconomic uncertainties. Stay tuned to learn how investors and analysts are navigating these subtle changes to better anticipate the evolving story around Synchrony Financial.

Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Synchrony Financial.

???? Bullish Takeaways

Several analysts increased their price targets for Synchrony Financial following the company's recent earnings report and business updates, reflecting greater confidence in its revenue growth and credit performance.

Deutsche Bank twice raised their price target, most recently to $95, maintaining a Buy rating and highlighting the market's comfort with benign credit trends along with the expectation of renewed revenue growth.

Barclays lifted its target to $86, citing the benefits of additional share buybacks and improved credit. Positive implications from the credit unwind and the launch at Walmart are also seen as favorable for growth momentum.

HSBC upgraded Synchrony to Buy with an $81 price target, underscoring mounting bullishness around the stock.

Citizens JMP boosted its target to $88, remaining Outperform, and noted management's constructive commentary on improved credit results. This suggests further upside could be possible if this trend continues.

BofA increased its price target to $84, expressing confidence that loan growth has troughed and is positioned to accelerate. This outlook is supported by improving spending trends and the Walmart program launch.

Morgan Stanley raised its price target to $82 and now has an Equal Weight rating, observing that lower interest rates and improving near-term credit performance are reducing downside risks for the stock.

Analysts cite solid execution and cost control, with growth initiatives (such as Walmart) and credit resilience as key upside drivers. Some note that much of the upside may already be reflected in current valuations, leaving less room for positive surprises in the near term.

???? Bearish Takeaways

JPMorgan downgraded Synchrony to Neutral from Overweight, lowering its price target to $75 from $80 and emphasizing its preference for peers with more defensive credit profiles. The firm cites Synchrony’s position in the payment hierarchy and concerns about higher delinquency rates as key risks.

Barclays, while raising its target, cautioned that investors remain watchful over near-term credit and consumer health. Ongoing vigilance is warranted given recent rate dynamics and market conditions.

UBS maintained a Neutral stance with a modest target increase to $79, highlighting selective optimism after bank stock rallies and advising careful stock selection given valuation considerations.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

Deutsche Bank raised Synchrony Financial's price target to $93 from $91. The analysts maintained a Buy rating and expressed continued confidence in the company's revenue growth and stable credit performance following its third-quarter report.

Synchrony and The Toro Company launched a new credit card program. This initiative aims to offer innovative financing options for Toro, Exmark, Spartan, and Z Turf Equipment dealers. The program introduces digital applications, special financing offers, and enhanced underwriting tools.

Between July and September 2025, Synchrony repurchased 12.1 million shares for a total of $861.1 million. The company successfully completed its buyback program announced earlier that year, reinforcing its commitment to shareholder returns.

Synchrony expanded its health and wellness financing business through collaborations with Pumpkin Pet Insurance, mClub, and Audibel. These partnerships broaden support for veterinary and hearing care services.

Fair Value: Increased slightly from $82.57 to $82.74. This indicates a marginal uptick in analysts' intrinsic value estimates.

Discount Rate: Decreased modestly from 9.12% to 9.05%, which suggests a slightly lower risk premium is being applied to future cash flows.

Revenue Growth: Edged down marginally from 19.83% to 19.81%. This reflects a minor adjustment in growth projections.

Net Profit Margin: Improved fractionally from 17.88% to 17.90%. This signals a small enhancement in profitability expectations.

Future P/E: Dipped insignificantly from 10.45x to 10.45x, indicating virtually unchanged expectations for forward earnings multiples.

A Narrative connects a company’s real-world story to the numbers behind it, including your view of future revenue, earnings, and fair value. It is a simple and powerful tool available on Simply Wall St’s Community page, making it easy to see how the facts and forecasts fit together. Narratives help investors decide when to buy or sell by linking Fair Value to share price, and they automatically update as new news or earnings are released.

See the latest thinking and analyst arguments for Synchrony Financial in the original Narrative on Simply Wall St and stay ahead of these key developments:

How partnerships with major retailers and new digital payment products are supporting stable earnings, revenue growth, and customer retention.

The impact of Synchrony’s investment in AI and analytics on operational efficiency, risk management, and long-term growth potential.

The evolving risks and opportunities from fintech competition, shifting consumer behavior, and the need for ongoing technology investment.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SYF.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com